๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Blood Cancer

Key Longitudinal Associations With Risk and Glioblastoma Outcomes NCT06625684n/a1 site๐Ÿ“ Durham Duke University Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma NCT02605421Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Thiotepa, Cyclophosphamide, Melphalan, Etoposide, Carboplatin A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML NCT05735184Phase 144 sites๐Ÿ“ Phoenix๐Ÿ“ La Jolla๐Ÿ“ Los Angeles Kura Oncology, Inc. ยท Tests: Ziftomenib, Venetoclax, Azacitidine, Daunorubicin, Cytarabine A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma NCT07284758Phase 260 sites๐Ÿ“ Huntsville๐Ÿ“ Phoenix๐Ÿ“ Scottsdale C4 Therapeutics, Inc. ยท Tests: Cemsidomide, Dexamethasone Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance NCT06483100Phase 21 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: Elrantamab, clonoSEQ TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies NCT06484816Phase 11 site๐Ÿ“ Hangzhou Shenzhen TargetRx Co., Ltd. ยท Tests: TGRX-1942 Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma NCT05896228Phase 21 site๐Ÿ“ Miami Benjamin T Diamond, MD ยท Tests: Iberdomide, Carfilzomib, Daratumumab, Dexamethasone, Acetaminophen A Study to Evaluate Efficacy, Safety, and PK of XEMBIFYยฎ+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma NCT05645107Phase 362 sites๐Ÿ“ Bullhead City๐Ÿ“ Huntington Park๐Ÿ“ St. Petersburg Grifols Therapeutics LLC ยท Tests: Xembify, Placebo In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET NCT05093335EARLY Phase 11 site๐Ÿ“ New York Memorial Sloan Kettering Cancer Center ยท Tests: [68Ga]-Pentixafor A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Ann Arbor Incyte Corporation ยท Tests: INCA036873 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: TCRฮฑฮฒ+/CD19+ depleted Haploidentical HSCT, Zoledronate Universal CAR-T Cell Therapy for MM NCT07248176NA1 site๐Ÿ“ Shanghai Bioray Laboratories ยท Tests: Targeted BCMA Gene-Modified Allogeneic Chimeric Antigen Receptor T-Cell Injection CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study NCT06644625n/a1 site๐Ÿ“ Charlotte Wake Forest University Health Sciences ยท Tests: Blood draw for the laboratory assessment Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy NCT05646576NA1 site๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: Palliative Care, Usual Care Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India NCT07209917NA4 sites๐Ÿ“ Bangalore๐Ÿ“ Bangalore๐Ÿ“ Bangalore University of California, Irvine ยท Tests: SAKHI HPV Intervention, Enhanced Standard of Care (SOC+) A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma NCT07075328Phase 1, Phase 25 sites๐Ÿ“ Fukuoka๐Ÿ“ Sapporo๐Ÿ“ Kagoshima Otsuka Medical Devices Co., Ltd. Japan ยท Tests: Drug:5-ALA, Device:Photodynamic system Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE) NCT04991103Phase 21 site๐Ÿ“ Birmingham University of Alabama at Birmingham ยท Tests: DaraVRD/DaraVCD Cryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological Tumors NCT06829654NA1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna ยท Tests: Step 1, Step 2, Step 3, Step 4 A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments NCT05714839Phase 1, Phase 244 sites๐Ÿ“ Bullhead City๐Ÿ“ Los Angeles๐Ÿ“ Pembroke Pines GlaxoSmithKline ยท Tests: Belantamab, Belantamab mafodotin, Pomalidomide, Dexamethasone Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency NCT06090669Phase 11 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: TruSight Oncology, imatinib A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product NCT05768269n/a7 sites๐Ÿ“ Gilbert๐Ÿ“ Los Angeles๐Ÿ“ Baltimore Century Therapeutics, Inc. ยท Tests: No Intervention Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma NCT07236502NA2 sites๐Ÿ“ Maywood๐Ÿ“ Milwaukee Medical College of Wisconsin ยท Tests: Immediate intervention, Waitlist A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma NCT07760454Phase 1, Phase 22 sites๐Ÿ“ Suzhou๐Ÿ“ Shanghai UCARsgen Biotech Limited ยท Tests: CT0596 Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma NCT04234022n/a1 site๐Ÿ“ Wolverhampton The Royal Wolverhampton Hospitals NHS Trust ยท Tests: Zn-DDC, Lanalidomide with Zn-DDC, Pomalidomide with Zn-DDC Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma NCT06245629n/a1 site๐Ÿ“ Uppsala Uppsala University ยท Tests: Bortezomib-bendamustine-melphalan Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Delivery in Patients With Postoperative Recurrence of Malignant Glioma: A Single-arm Trial NCT06818331Phase 21 site๐Ÿ“ China The Third Affiliated hospital of Zhejiang Chinese Medical Uโ€ฆ ยท Tests: SMES+PTX, Paclitaxel, Specific mode electroacupuncture stimulation A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms NCT06034002Phase 113 sites๐Ÿ“ Duarte๐Ÿ“ Palo Alto๐Ÿ“ Miami Incyte Corporation ยท Tests: INCA033989, Ruxolitinib Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery NCT04209218NA1 site๐Ÿ“ Beijing Peking University First Hospital ยท Tests: Dexamethasone, Targeted blood pressure management, Placebo, Routine blood presure management Comparison of 40% Glucose Solution and Autologous Blood Patch Pleurodesis for Postoperative Air Leak After Lung Resections NCT06936969NA1 site๐Ÿ“ Poznan Wielkopolskie Centrum Pulmonologii i Torakochirurgii ยท Tests: Autologous blood patch pleurodesis, 40% glucose solution pleurodesis
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy